Manandhar, N. R., Kayashta, G. K. and Acharya, P. K. (2018) “Dasatinib tyrosine kinase inhibitor as second and third line therapy in chronic myeloid leukemia: outcome of a Nepalese study”, Journal of Patan Academy of Health Sciences, 5(1), pp. 47–56. doi: 10.3126/jpahs.v5i1.24042.